Zydus Pharmaceuticals (USA) Inc. drugs
18 results
Acetazolamide (acetazolamide)
(acetaZOLAMIDE)Zydus Pharmaceuticals (USA) Inc.
Usage: Acetazolamide is indicated as an adjunctive treatment for edema related to congestive heart failure and drug use, various forms of epilepsy, and glaucoma. It is also used to prevent or alleviate symptoms of acute mountain sickness in climbers.
Acyclovir (acyclovir)
(acyclovir)Zydus Pharmaceuticals (USA) Inc.
Usage: Acyclovir capsules are indicated for the acute treatment of herpes zoster (shingles), the treatment of initial and recurrent episodes of genital herpes, and for the treatment of chickenpox (varicella).
Butalbital, acetaminophen, and caffeine (butalbital, acetaminophen, and caffeine)
(Butalbital, Acetaminophen, and Caffeine)Zydus Pharmaceuticals (USA) Inc.
Usage: Butalbital, acetaminophen, and caffeine tablets are indicated for relieving tension (or muscle contraction) headaches. However, there is limited evidence supporting their efficacy and safety for treating multiple recurrent headaches, and caution is advised due to the habit-forming nature of butalbital.
Cholestyramine (cholestyramine)
(CHOLESTYRAMINE)Zydus Pharmaceuticals (USA) Inc.
Usage: Cholestyramine for oral suspension is indicated as adjunctive therapy to lower elevated LDL cholesterol in patients with primary hypercholesterolemia unresponsive to diet. It also alleviates pruritus from partial biliary obstruction. Lipid profiles should guide treatment initiation and monitoring for optimal cholesterol management.
Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate (dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate)
(Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate)Zydus Pharmaceuticals (USA) Inc.
Usage: Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate extended-release capsules are indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in children, adolescents, and adults as part of a comprehensive treatment program, alongside psychological and educational measures.
Dextroamphetamine sulfate (dextroamphetamine sulfate)
(Dextroamphetamine Sulfate)Zydus Pharmaceuticals (USA) Inc.
Usage: Dextroamphetamine sulfate extended-release capsules are indicated for the treatment of narcolepsy and Attention Deficit Hyperactivity Disorder (ADHD) in children aged 6 to 16. They are part of a comprehensive treatment program, including psychological and educational measures, for managing symptoms that impair functioning across multiple settings.
Dextroamphetamine sulfate (dextroamphetamine sulfate)
(DEXTROAMPHETAMINE SULFATE)Zydus Pharmaceuticals (USA) Inc.
Usage: Dextroamphetamine Sulfate Tablets are indicated for narcolepsy and Attention Deficit Disorder with Hyperactivity. They should be part of a comprehensive treatment program for pediatric patients aged 3 to 16, addressing symptoms like distractibility, hyperactivity, emotional lability, and impulsivity.
Ethosuximide (ethosuximide)
(ethosuximide)Zydus Pharmaceuticals (USA) Inc.
Usage: Ethosuximide capsules are indicated for the control of absence (petit mal) epilepsy.
Glyburide and metformin hydrochloride (glyburide and metformin hydrochloride)
(glyburide and metformin hydrochloride)Zydus Pharmaceuticals (USA) Inc.
Usage: Glyburide and metformin hydrochloride tablets are indicated as an adjunct to diet and exercise for improving glycemic control in adults with type 2 diabetes mellitus.
Isosorbide mononitrate (isosorbide mononitrate)
(isosorbide mononitrate)Zydus Pharmaceuticals (USA) Inc.
Usage: Isosorbide mononitrate extended-release tablets are indicated for the prevention of angina pectoris caused by coronary artery disease. They are not suitable for aborting acute angina episodes due to their delayed onset of action.